Last reviewed · How we verify

NCT03512106

The Efficacy of the Acupuncture in the Treatment of Systemic Arterial Hypertension

Status unknown NA Last updated 30 April 2018
What this trial tests

NA trial testing Acupuncture in Arterial Hypertension in 86 participants. Status unknown.

Timeline
1 June 2018
Primary endpoint
1 December 2018
1 June 2019

Quick facts

Lead sponsorsilvia goldmeier
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment86
Start date1 June 2018
Primary completion1 December 2018
Estimated completion1 June 2019

Drugs / interventions tested

Conditions studied

Sponsor

silvia goldmeier

Who can join

45 and older, any sex, with Arterial Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There are few studies in the treatment of hypertension employing acupuncture as a blood pressure regulating technique. The Ministry of Health synthesized the inclusion of integrative and complementary practices within the Unique Health System, such as acupuncture. Our objective is to verify the effect of the acupuncture session on hypertensive patients, measured through ambulatory blood pressure monitoring (ABPM). In this way two groups of patients will be selected in a randomized clinical trial. In the first group, Chinese traditional acupuncture will be applied and in the second group the acupuncture sham will be applied.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Acupuncture

Trials testing the same drug.

Other recruiting trials for Arterial Hypertension

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03512106.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing